Rebecca Alexandra Dent
Overview
Explore the profile of Rebecca Alexandra Dent including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
385
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meng J, Tan J, Joseph C, Ye J, Lim J, Goh D, et al.
Lab Invest
. 2023 Dec;
104(3):100303.
PMID: 38103870
Triple-negative breast cancer (TNBC) has a poor prognosis with limited therapeutic options available for affected patients. Efforts are ongoing to identify surrogate markers for tumor-specific CD8 T cells that can...
2.
Yeong J, Goh D, Tan T, Tan B, Sivaraj H, Koh V, et al.
Mod Pathol
. 2023 Feb;
36(4):100056.
PMID: 36788078
Mutations in the PI3K pathway, particularly PIK3CA, were reported to be intimately associated with triple-negative breast cancer (TNBC) progression and the development of treatment resistance. We profiled PIK3CA and other...
3.
Seet A, Tan A, Tan T, Ng M, Tai D, Lam J, et al.
JCO Precis Oncol
. 2021 Jul;
5.
PMID: 34250396
Purpose: Precision oncology has transformed the management of advanced cancers through implementation of advanced molecular profiling technologies to identify increasingly defined subsets of patients and match them to appropriate therapy....
4.
Finkelstein E, Baid D, Cheung Y, Schweitzer M, Malhotra C, Volpp K, et al.
Psychooncology
. 2021 Mar;
30(5):780-788.
PMID: 33739561
Objective: Many patients with advanced illness are unrealistically optimistic about their prognosis. We test for the presence of several cognitive biases, including optimism bias, illusion of superiority, self-deception, misattribution, and...
5.
Kee G, Tan R, Rehena S, Lee J, Zaw M, Lian W, et al.
World J Clin Oncol
. 2020 Jul;
11(5):283-293.
PMID: 32728531
Background: Invasive lobular carcinomas (ILC) form 5%-10% of breast cancer and rarely show overexpression of human epidermal growth factor receptor 2 (). Aim: To describe the prevalence and prognostic factors...
6.
Lai C, Yeong J, Tan A, Ong C, Lee B, Lim J, et al.
Breast Cancer Res Treat
. 2019 Aug;
178(2):295-305.
PMID: 31410680
Purpose: We used multiplex immunofluorescence (mIF) to determine whether mitotic rate represents an independent prognostic marker in triple-negative breast cancer (TNBC). Secondary aims were to confirm the prognostic significance of...
7.
Tan A, Yeong J, Lai C, Ong C, Lee B, Lim J, et al.
Virchows Arch
. 2019 Aug;
475(6):709-725.
PMID: 31407032
The proliferation marker Ki-67 is frequently used to assess aggressiveness in the pathological evaluation of cancer, but its role remains uncertain in triple-negative breast cancer (TNBC). We aimed to quantify...
8.
De Guzman R, Malik M, de Lima Lopes Jr G, Dent R, Dawood S
J Glob Oncol
. 2018 Sep;
4:1-3.
PMID: 30241270
No abstract available.
9.
Tan T, Chan J, Kamis S, Dent R
Chin Clin Oncol
. 2018 May;
7(2):13.
PMID: 29764158
The immune system plays a complex role in the recognition/prevention, early eradication as well as progression of cancer. Recently, we have witnessed great momentum in the field of immuno-oncology. Checkpoint...
10.
Gianni L, Mansutti M, Anton A, Calvo L, Bisagni G, Bermejo B, et al.
JAMA Oncol
. 2018 Jan;
4(3):302-308.
PMID: 29327055
Importance: Studies of neoadjuvant chemotherapy regimens using anthracyclines followed by taxanes have reported a doubling of pathological complete remission (pCR) rates compared with anthracycline-based regimens alone. A reverse sequence did...